rs312262782
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025137.4(SPG11):c.6739_6742delGAGT(p.Glu2247LeufsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000496 in 1,613,580 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025137.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 11Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina, G2P
- amyotrophic lateral sclerosis type 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Charcot-Marie-Tooth disease axonal type 2XInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPG11 | NM_025137.4 | c.6739_6742delGAGT | p.Glu2247LeufsTer14 | frameshift_variant | Exon 36 of 40 | ENST00000261866.12 | NP_079413.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPG11 | ENST00000261866.12 | c.6739_6742delGAGT | p.Glu2247LeufsTer14 | frameshift_variant | Exon 36 of 40 | 1 | NM_025137.4 | ENSP00000261866.7 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151882Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251434 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461698Hom.: 0 AF XY: 0.0000536 AC XY: 39AN XY: 727166 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151882Hom.: 0 Cov.: 31 AF XY: 0.0000540 AC XY: 4AN XY: 74142 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 11 Pathogenic:3Other:1
This sequence change creates a premature translational stop signal (p.Glu2247Leufs*14) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs312262782, gnomAD 0.009%). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia (PMID: 18079167, 20301389, 20571989, 23443022, 26556829). ClinVar contains an entry for this variant (Variation ID: 41348). For these reasons, this variant has been classified as Pathogenic.
Found in trans with another loss-of-function variant
Hereditary spastic paraplegia 11;C1865864:Amyotrophic lateral sclerosis type 5;C5569024:Charcot-Marie-Tooth disease axonal type 2X Pathogenic:1Other:1
Variant classified as Pathogenic and reported on 08-05-2021 by Invitae. GenomeConnect-InvitaePIN assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
Inborn genetic diseases Pathogenic:1
The c.6739_6742delGAGT pathogenic mutation, located in coding exon 36 of the SPG11 gene, results from a deletion of 4 nucleotides at nucleotide positions 6739 to 6742, causing a translational frameshift with a predicted alternate stop codon (p.E2247Lfs*14). This alteration has been detected as compound heterozygous or homozygous in multiple unrelated individuals with SPG11-related neurologic disorders (Stevanin G et al. Brain, 2008 Mar;131:772-84; de Bot ST et al. Eur J Hum Genet, 2013 Nov;21:1312-5; Denora PS et al. Brain, 2016 06;139:1723-34; Montecchiani C et al. Brain, 2016 Jan;139:73-85). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20571989, 18079167, 26556829, 20390432, 31980526, 27016404, 35572931)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at